In tumour cells that evade the NK cells, galectin-3 binds to poly-N-acetyllactosamine in the NKG2D-binding site of MICA, thereby preventing the interaction of MICA with NK2GD, and the apoptotic mechanisms are not triggered to promote longer circulation of the tumour cells [70,75]. The gene discussed is KLRK1; the disease is neoplasm.